Sunshine Act Meetings, 4666-4667 [2022-01953]

Download as PDF 4666 Federal Register / Vol. 87, No. 19 / Friday, January 28, 2022 / Notices • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to PDR.Resource@nrc.gov. For the convenience of the reader, instructions about obtaining materials referenced in this document are provided in the ‘‘Availability of Documents’’ section. • NRC’s PDR: You may examine and purchase copies of public documents, by appointment, at the NRC’s PDR, Room P1 B35, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. To make an appointment to visit the PDR, please send an email to PDR.Resource@nrc.gov or call 1–800–397–4209 or 301–415– 4737, between 8:00 a.m. and 4:00 p.m. (ET), Monday through Friday, except Federal holidays. FOR FURTHER INFORMATION CONTACT: George Alexander, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–6755; email: George.Alexander@nrc.gov. SUPPLEMENTARY INFORMATION: I. Background The Sigma-Aldrich Company’s (Sigma’s) Fort Mims Site is located at 11542 Fort Mims Drive, Maryland Heights, Missouri in a commercial/ industrial park. The site consists of a 3acre parcel of land previously used for the radiolabeling of chemicals with carbon-14 and tritium. II. Discussion By email dated August 22, 2019, the NRC received an application to amend Sigma’s decommissioning plan. That application was supplemented by letter dated April 27, 2020, requesting a license amendment for the termination of NRC Materials License No. 24– 16273–01, and by letter dated October 19, 2020, providing the NRC Form 313 ‘‘Application for Materials License’’ for this action. By email dated July 31, 2020, the NRC staff accepted for detailed technical review Sigma’s license amendment request to amend the decommissioning plan and terminate the license. The NRC staff reviewed the revised decommissioning plan with the sitespecific dose model and license termination request. Based on Sigma’s dose analysis and the NRC’s independent and confirmatory surveys and analyses, the NRC staff concluded in a safety evaluation report dated November 16, 2021, that the Fort Mims Site met the dose criteria for unrestricted use and that the residual radioactivity is as low as reasonably achievable, consistent with section 20.1402 of title 10 of the Code of Federal Regulations, ‘‘Radiological criteria for unrestricted use.’’ Based on an environmental assessment dated November 12, 2021, NRC staff concluded that there would be no significant environmental impacts. Accordingly, NRC Materials License No. 24–16273–01 for the Fort Mims Site was terminated. III. Availability of Documents The documents identified in the following table are available to interested persons through ADAMS, as indicated. ADAMS accession No. Document NRC Approval of Sigma-Aldrich Company’s Fort Mims Facility Decommissioning Plan, dated May 12, 2009 ............................. Sigma-Aldrich Fort Mims Site Revised Decommissioning Plan, dated June 27, 2019 ................................................................... Transmittal Email—Sigma-Aldrich Fort Mims Revised Decommissioning Plan, dated August 22, 2019 ....................................... Sigma-Aldrich Fort Mims Site Request for License Termination, dated April 27, 2020 .................................................................. Transmittal Email—NRC Acceptance Review of Revised Decommissioning Plan and License Termination Request, dated July 31, 2020. Sigma-Aldrich Fort Mims Site Revised Decommissioning Plan: NRC Form 313, ‘‘Application for Materials License,’’ dated October 19, 2020. NRC Environmental Assessment and Finding of No Significant Impact Related to the Issuance of a License Amendment for the Sigma-Aldrich Fort Mims Site, dated November 12, 2021. NRC Safety Evaluation Report of Revised Decommissioning Plan and License Termination Request for the Sigma-Aldrich Fort Mims Site, dated November 16, 2021. NRC Materials License 24–16273–01 Termination Amendment 21, dated November 16, 2021 ................................................... Dated: January 25, 2022. For the Nuclear Regulatory Commission. Randolph W. Von Till, Chief, Uranium Recovery and Materials Decommissioning Branch, Division of Decommissioning, Uranium Recovery and Waste Programs, Office of Nuclear Material Safety and Safeguards. [FR Doc. 2022–01754 Filed 1–27–22; 8:45 am] jspears on DSK121TN23PROD with NOTICES1 BILLING CODE 7590–01–P [NRC–2022–0001] Sunshine Act Meetings Weeks of January 31, February 7, 14, 21, 28, March 7, 2022. TIME AND DATE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. PLACE: Public. There are no meetings scheduled for the week of January 31, 2022. 18:03 Jan 27, 2022 Jkt 256001 PO 00000 Frm 00115 Fmt 4703 Sfmt 4703 ML21277A097 ML21300A384 ML21300A383 Tuesday, February 8, 2022 Week of January 31, 2022 VerDate Sep<11>2014 ML20294A191 Week of February 7, 2022—Tentative NUCLEAR REGULATORY COMMISSION STATUS: ML091330309 ML19273A160 ML19273A163 ML20120A544 ML20213C693 10:00 a.m. Meeting with the Organization of Agreement States and the Conference of Radiation Control Program Directors (Public Meeting); (Contact: Celimar Valentin-Rodriguez: 301–415– 7124). Additional Information: The public is invited to attend the Commission’s meeting live by webcast at the Web address—https://video.nrc.gov/. For those who would like to attend in person, note that all visitors are required to complete the NRC Self-Health Assessment and Certification of Vaccination forms. Visitors who certify E:\FR\FM\28JAN1.SGM 28JAN1 Federal Register / Vol. 87, No. 19 / Friday, January 28, 2022 / Notices that they are not fully vaccinated or decline to complete the certification must have proof of a negative Food and Drug Administration-approved polymerase chain reaction (PCR) or Antigen (including rapid tests) COVID– 19 test specimen collection from no later than the previous 3 days prior to entry to an NRC facility. The forms and additional information can be found here https://www.nrc.gov/about-nrc/ covid-19/guidance-for-visitors-to-nrcfacilities.pdf. Week of February 14, 2022—Tentative There are no meetings scheduled for the week of February 14, 2022. Week of February 21, 2022—Tentative Thursday, February 24, 2022 10:00 a.m. Briefing on Regulatory Research Program Activities (Public Meeting); (Contact: Nick Difrancesco: 301–415–1115). Additional Information: The public is invited to attend the Commission’s meeting live by webcast at the Web address—https://video.nrc.gov/. For those who would like to attend in person, note that all visitors are required to complete the NRC Self-Health Assessment and Certification of Vaccination forms. Visitors who certify that they are not fully vaccinated or decline to complete the certification must have proof of a negative Food and Drug Administration-approved polymerase chain reaction (PCR) or Antigen (including rapid tests) COVID– 19 test specimen collection from no later than the previous 3 days prior to entry to an NRC facility. The forms and additional information can be found here https://www.nrc.gov/about-nrc/ covid-19/guidance-for-visitors-to-nrcfacilities.pdf. Week of February 28, 2022—Tentative There are no meetings scheduled for the week of February 28, 2022. Week of March 7, 2022—Tentative There are no meetings scheduled for the week of March 7, 2022. jspears on DSK121TN23PROD with NOTICES1 CONTACT PERSON FOR MORE INFORMATION: For more information or to verify the status of meetings, contact Wesley Held at 301–287–3591 or via email at Wesley.Held@nrc.gov. The schedule for Commission meetings is subject to change on short notice. The NRC Commission Meeting Schedule can be found on the internet at: https://www.nrc.gov/public-involve/ public-meetings/schedule.html. The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you VerDate Sep<11>2014 18:03 Jan 27, 2022 Jkt 256001 need a reasonable accommodation to participate in these public meetings or need this meeting notice or the transcript or other information from the public meetings in another format (e.g., braille, large print), please notify Anne Silk, NRC Disability Program Specialist, at 301–287–0745, by videophone at 240–428–3217, or by email at Anne.Silk@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. Members of the public may request to receive this information electronically. If you would like to be added to the distribution, please contact the Nuclear Regulatory Commission, Office of the Secretary, Washington, DC 20555, at 301–415–1969, or by email at Tyesha.Bush@nrc.gov or Betty.Thweatt@ nrc.gov. The NRC is holding the meetings under the authority of the Government in the Sunshine Act, 5 U.S.C. 552b. Dated: January 26, 2022. For the Nuclear Regulatory Commission. Wesley W. Held, Policy Coordinator, Office of the Secretary. [FR Doc. 2022–01953 Filed 1–26–22; 4:15 pm] BILLING CODE 7590–01–P PENSION BENEFIT GUARANTY CORPORATION Proposed Submission of Information Collection for OMB Review; Comment Request; Medical Exception Request Pension Benefit Guaranty Corporation. ACTION: Notice of intent to request extension of OMB approval of information collection. AGENCY: The Pension Benefit Guaranty Corporation (PBGC) intends to request that the Office of Management and Budget (OMB) extend approval, without change, under the Paperwork Reduction Act, of a collection of information for its employees to request a medical exception to the COVID–19 vaccination requirement. DATES: Comments must be submitted on or before March 29, 2022. ADDRESSES: Comments may be submitted by any of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • Email: paperwork.comments@ pbgc.gov. Refer to OMB control number 1212–0075 in the subject line. • Mail or Hand Delivery: Regulatory Affairs Division, Office of the General Counsel, Pension Benefit Guaranty SUMMARY: PO 00000 Frm 00116 Fmt 4703 Sfmt 4703 4667 Corporation, 1200 K Street NW, Washington, DC 20005–4026. Commenters are strongly encouraged to submit public comments electronically. PBGC expects to have limited personnel available to process public comments that are submitted on paper through mail. Until further notice, any comments submitted on paper will be considered to the extent practicable. All submissions received must include the agency’s name (Pension Benefit Guaranty Corporation, or PBGC) and refer to OMB control number 1212– 0075. All comments received will be posted without change to PBGC’s website, https://www.pbgc.gov, including any personal information provided. Commenters should not include any information for which disclosure is restricted by statute, such as trade secrets and commercial or financial information (‘‘confidential business information’’). Submission of confidential business information without a request for protected treatment constitutes a waiver of any claims of confidentiality. Copies of the collection of information may be obtained by writing to Disclosure Division, Office of the General Counsel, Pension Benefit Guaranty Corporation, 1200 K Street NW, Washington, DC 20005–4026, or calling 202–229–4040 during normal business hours. TTY users may call the Federal Relay Service toll-free at 800– 877–8339 and ask to be connected to 202–229–4040. FOR FURTHER INFORMATION CONTACT: Melissa Rifkin (rifkin.melissa@ pbgc.gov), Attorney, Regulatory Affairs Division, Office of the General Counsel, Pension Benefit Guaranty Corporation, 1200 K Street NW, Washington, DC 20005–4026; 202–229–6563. (TTY and TDD users may call the Federal relay service toll-free at 800–877–8339 and ask to be connected to 202–229–6563.) SUPPLEMENTARY INFORMATION: Under Executive Order 14043, every Federal agency must ‘‘implement, to the extent consistent with applicable law, a program to require COVID–19 vaccination for all of its Federal employees, with exceptions only as required by law.’’ In following this directive, the Pension Benefit Guaranty Corporation (PBGC) has a requirement that its employees must receive and submit proof of a COVID–19 vaccination. As required by 29 U.S.C. 701 et seq. and 29 CFR part 1630, PBGC allows an exception from the vaccination requirement for employees who demonstrate medical reasons or disabilities that would make the COVID–19 vaccine unsafe for them. To E:\FR\FM\28JAN1.SGM 28JAN1

Agencies

NUCLEAR REGULATORY COMMISSION

[Federal Register Volume 87, Number 19 (Friday, January 28, 2022)]
[Notices]
[Pages 4666-4667]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01953]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2022-0001]


Sunshine Act Meetings

TIME AND DATE: Weeks of January 31, February 7, 14, 21, 28, March 7, 
2022.

PLACE: Commissioners' Conference Room, 11555 Rockville Pike, Rockville, 
Maryland.

STATUS: Public.

Week of January 31, 2022

    There are no meetings scheduled for the week of January 31, 2022.

Week of February 7, 2022--Tentative

Tuesday, February 8, 2022

10:00 a.m. Meeting with the Organization of Agreement States and the 
Conference of Radiation Control Program Directors (Public Meeting); 
(Contact: Celimar Valentin-Rodriguez: 301-415-7124).

    Additional Information: The public is invited to attend the 
Commission's meeting live by webcast at the Web address--https://video.nrc.gov/. For those who would like to attend in person, note that 
all visitors are required to complete the NRC Self-Health Assessment 
and Certification of Vaccination forms. Visitors who certify

[[Page 4667]]

that they are not fully vaccinated or decline to complete the 
certification must have proof of a negative Food and Drug 
Administration-approved polymerase chain reaction (PCR) or Antigen 
(including rapid tests) COVID-19 test specimen collection from no later 
than the previous 3 days prior to entry to an NRC facility. The forms 
and additional information can be found here https://www.nrc.gov/about-nrc/covid-19/guidance-for-visitors-to-nrc-facilities.pdf.

Week of February 14, 2022--Tentative

    There are no meetings scheduled for the week of February 14, 2022.

Week of February 21, 2022--Tentative

Thursday, February 24, 2022

10:00 a.m. Briefing on Regulatory Research Program Activities (Public 
Meeting); (Contact: Nick Difrancesco: 301-415-1115).

    Additional Information: The public is invited to attend the 
Commission's meeting live by webcast at the Web address--https://video.nrc.gov/. For those who would like to attend in person, note that 
all visitors are required to complete the NRC Self-Health Assessment 
and Certification of Vaccination forms. Visitors who certify that they 
are not fully vaccinated or decline to complete the certification must 
have proof of a negative Food and Drug Administration-approved 
polymerase chain reaction (PCR) or Antigen (including rapid tests) 
COVID-19 test specimen collection from no later than the previous 3 
days prior to entry to an NRC facility. The forms and additional 
information can be found here https://www.nrc.gov/about-nrc/covid-19/guidance-for-visitors-to-nrc-facilities.pdf.

Week of February 28, 2022--Tentative

    There are no meetings scheduled for the week of February 28, 2022.

Week of March 7, 2022--Tentative

    There are no meetings scheduled for the week of March 7, 2022.

CONTACT PERSON FOR MORE INFORMATION: For more information or to verify 
the status of meetings, contact Wesley Held at 301-287-3591 or via 
email at [email protected]. The schedule for Commission meetings is 
subject to change on short notice.
    The NRC Commission Meeting Schedule can be found on the internet 
at: https://www.nrc.gov/public-involve/public-meetings/schedule.html.
    The NRC provides reasonable accommodation to individuals with 
disabilities where appropriate. If you need a reasonable accommodation 
to participate in these public meetings or need this meeting notice or 
the transcript or other information from the public meetings in another 
format (e.g., braille, large print), please notify Anne Silk, NRC 
Disability Program Specialist, at 301-287-0745, by videophone at 240-
428-3217, or by email at [email protected]. Determinations on requests 
for reasonable accommodation will be made on a case-by-case basis.
    Members of the public may request to receive this information 
electronically. If you would like to be added to the distribution, 
please contact the Nuclear Regulatory Commission, Office of the 
Secretary, Washington, DC 20555, at 301-415-1969, or by email at 
[email protected] or [email protected].
    The NRC is holding the meetings under the authority of the 
Government in the Sunshine Act, 5 U.S.C. 552b.

    Dated: January 26, 2022.

    For the Nuclear Regulatory Commission.
Wesley W. Held,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2022-01953 Filed 1-26-22; 4:15 pm]
BILLING CODE 7590-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.